Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
BMC Rheumatology|January 17, 2025
Use of disease modifying anti-rheumatic drugs and risk of multiple myeloma in US Veterans with rheumatoid arthritisKate Tokareva, Alexander C Peterson, Aaron Baraff, et al.
JAMA Network Open|April 3, 2024
Treatment Access for Gastrointestinal Stromal Tumor in Predominantly Low- and Middle-Income CountriesEdward Lloyd Briercheck, J Michael Wrigglesworth, Ines Garcia-Gonzalez, et al.
Science Immunology|April 4, 2017
Tracking the Fate and Origin of Clinically Relevant Adoptively Transferred CD8+ T Cells In VivoAude G Chapuis, Cindy Desmarais, Ryan Emerson, et al.
Blood Cancer Discovery|May 15, 2024
Long-term Remissions Following CD20-Directed Chimeric Antigen Receptor-Adoptive T-cell TherapyGeorge Mo, Sang Y Lee, David G Coffey, et al.
JCI Insight|May 24, 2016
Origin and evolution of the T cell repertoire after posttransplantation cyclophosphamideChristopher G Kanakry, David G Coffey, Andrea M H Towlerton, et al.
JCO Precision Oncology|July 12, 2021
High-Throughput Drug Screening and Multi-Omic Analysis to Guide Individualized Treatment for Multiple MyelomaDavid G Coffey, Andrew J Cowan, Bret DeGraaff, et al.
Haematologica|April 17, 2025
Outcomes and treatment patterns in primary and secondary plasma cell leukemia: insights from a large US cohort studyShagun Singh, Supriya Peshin, Betsy C Wertheim, et al.
Biorxiv : the Preprint Server for Biology|August 7, 2023
The Vk*MYC Mouse Model recapitulates human multiple myeloma evolution and genomic diversityFrancesco Maura, David G Coffey, Caleb K Stein, et al.
Nature Communications|May 7, 2024
The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humansFrancesco Maura, David G Coffey, Caleb K Stein, et al.
Pageof 4